vorinostat has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sailhamer, EA | 1 |
| Li, Y | 1 |
| Smith, EJ | 1 |
| Shuja, F | 1 |
| Shults, C | 1 |
| Liu, B | 1 |
| Soupir, C | 1 |
| deMoya, M | 1 |
| Velmahos, G | 1 |
| Alam, HB | 1 |
1 other study available for vorinostat and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans.
Topics: Abdominal Injuries; Acetylation; Adult; Animals; Cell Culture Techniques; Female; Hemorrhage; Histon | 2008 |